{"id":8629,"date":"2022-11-28T00:00:00","date_gmt":"2022-11-28T05:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/"},"modified":"2023-06-14T09:27:39","modified_gmt":"2023-06-14T13:27:39","slug":"parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials","status":"publish","type":"announce_or_event","link":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/","title":{"rendered":"Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials"},"content":{"rendered":"<p>Please join us &#8230;<\/p>\n<p><strong>When:<\/strong> Thursday, December 1, 2022, 12&#x2013;1 p.m.<\/p>\n<p><strong>Where:<\/strong> Join Zoom Meeting <a href=\"https:\/\/us06web.zoom.us\/j\/82435258546\" title=\"opens external link\">https:\/\/us06web.zoom.us\/j\/82435258546<\/a>, Meeting ID: 824 3525 8546. Meeting password: 1234 <strong>OR<\/strong> in person in G Wing, 1st Floor (Linton Boardroom)<\/p>\n<p><strong>Who: <\/strong><a href=\"\/ices-scientists\/eileen-rakovitch\/\"><\/a>Priti Gros, MD FRCPC; Movement Disorders Fellow, MSc candidate, Clinical Epidemiology &amp; Healthcare Research<\/p>\n<p><strong>Topic: <\/strong>Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials<\/p>\n<p><strong>Learning Objectives: <\/strong><\/p>\n<ol>\n<li>Determine whether Parkinson Disease (PD) patients likely to be recruited in randomized controlled trials are representative of the broader Parkinson Disease population?<\/li>\n<li>Test the association between the Movement Disorders Society Unified Parkinson Disease Rating Scale and measures of PD progression from health services data, in order to assess the suitability of administrative data-derived measures in future trial extension studies.<\/li>\n<li>Assess the relationship between phosphoglycerate kinase 1 activators and measures of PD progression (time to PD milestones) in the real-world setting by emulating a target trial.<\/li>\n<\/ol>\n<div class=\"row\">\n<div class=\"four columns\"><img loading=\"lazy\" decoding=\"async\" height=\"317\" alt=\"Priti Gros\" width=\"250\" src=\"\/wp-content\/uploads\/2023\/05\/Priti_Gros.png\"> <\/p>\n<p><span class=\"grey\" style=\"font-size: 12px; font-weight: bold; display: block; color: #5b5656;\">Priti Gros<\/span><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Please join us &#8230; When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\/\/us06web.zoom.us\/j\/82435258546, Meeting ID: 824 3525 8546. Meeting password: 1234 OR in person in G Wing, 1st Floor (Linton Boardroom) Who: Priti Gros, MD FRCPC; Movement Disorders Fellow, MSc candidate, Clinical Epidemiology &amp; Healthcare Research Topic: Parkinson disease progression measures in [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"class_list":["post-8629","announce_or_event","type-announce_or_event","status-publish","hentry"],"acf":{"ices_scientist":[],"research_program":[],"site":[6733],"journal_article":[],"news_release":[],"infographic":[],"sitecore_item_id":"310BB17B-44FD-4336-8E3C-0493C41DFF9E","sitecore_item_name":"Evaluative-Clinical-Sciences-Rounds-December-01-2022","sitecore_field_values":"{\n  \"Show in sitemap\": null,\n  \"Show in navigation\": null,\n  \"Content\": \"<p>Please join us ...<\/p>n<p><strong>When:<\/strong> Thursday, December 1, 2022, 12&ndash;1 p.m.<\/p>n<p><strong>Where:<\/strong> Join Zoom Meeting <a href=\"https:\/\/us06web.zoom.us\/j\/82435258546\" title=\"opens external link\">https:\/\/us06web.zoom.us\/j\/82435258546<\/a>, Meeting ID: 824 3525 8546. Meeting password: 1234 <strong>OR<\/strong> in person in G Wing, 1st Floor (Linton Boardroom)<\/p>n<p><strong>Who: <\/strong><a href=\"~\/link.aspx?_id=CFFF93666EFD41AF8E1E5C38A65A0CE9&amp;_z=z\"><\/a>Priti Gros, MD FRCPC; Movement Disorders Fellow, MSc candidate, Clinical Epidemiology &amp; Healthcare Research<\/p>n<p><strong>Topic: <\/strong>Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials<\/p>n<p><strong>Learning Objectives: <\/strong><\/p>n<ol>n    <li>Determine whether Parkinson Disease (PD) patients likely to be recruited in randomized controlled trials are representative of the broader Parkinson Disease population?<\/li>n    <li>Test the association between the Movement Disorders Society Unified Parkinson Disease Rating Scale and measures of PD progression from health services data, in order to assess the suitability of administrative data-derived measures in future trial extension studies.<\/li>n    <li>Assess the relationship between phosphoglycerate kinase 1 activators and measures of PD progression (time to PD milestones) in the real-world setting by emulating a target trial.<\/li>n<\/ol>n<div class=\"row\">n<div class=\"four columns\"><img height=\"317\" alt=\"Priti Gros\" width=\"250\" src=\"~\/media\/63789E8783174AF593B43FE2CA63341B.ashx\" \/> <br \/>n<p><span class=\"grey\" style=\"font-size: 12px; font-weight: bold; display: block; color: #5b5656;\">Priti Gros<\/span><\/p>n<\/div>n<\/div>\",\n  \"Title\": \"Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials\",\n  \"Short title\": null,\n  \"Teaser image\": \"<image mediaid=\"{E1BCE7CE-7B52-4F43-8D31-5AFFC60356E8}\" mediapath=\"\/Images\/ovoid-shape\/ovoid-1\" src=\"~\/media\/E1BCE7CE7B524F438D315AFFC60356E8.ashx\" alt=\"healthcare ovoid\" height=\"\" width=\"\" hspace=\"\" vspace=\"\" \/>\",\n  \"Image\": \"<image mediaid=\"{E1BCE7CE-7B52-4F43-8D31-5AFFC60356E8}\" mediapath=\"\/Images\/ovoid-shape\/ovoid-1\" src=\"~\/media\/E1BCE7CE7B524F438D315AFFC60356E8.ashx\" alt=\"healthcare ovoid\" height=\"\" width=\"\" hspace=\"\" vspace=\"\" \/>\",\n  \"Summary\": \"Join us Thursday December 1 for Evaluative Clinical Sciences Rounds when Dr. Priti Gros discusses the relationship between phosphoglycerate kinase 1 activators and measures of PD progression.\",\n  \"ICES Scientists\": null,\n  \"ICES Locations\": \"{4FCAABBA-14A5-42E6-8F33-BC6C2F1D9908}\",\n  \"Research Programs\": null,\n  \"Posted Date\": \"20221128T000000\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Newsroom\/Announcements-and-Events\/2022\/Evaluative-Clinical-Sciences-Rounds-December-01-2022"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials<\/title>\n<meta name=\"description\" content=\"Please join us ... When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\/\/us06web.zoom.us\/j\/82435258546, Meeting ID: 824 3525\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials\" \/>\n<meta property=\"og:description\" content=\"Please join us ... When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\/\/us06web.zoom.us\/j\/82435258546, Meeting ID: 824 3525\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T13:27:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/announcements-and-events\\\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/announcements-and-events\\\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\\\/\",\"name\":\"ICES | Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2022-11-28T05:00:00+00:00\",\"dateModified\":\"2023-06-14T13:27:39+00:00\",\"description\":\"Please join us ... When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\\\/\\\/us06web.zoom.us\\\/j\\\/82435258546, Meeting ID: 824 3525\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/announcements-and-events\\\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/announcements-and-events\\\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/announcements-and-events\\\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Announcements & Events\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/announcements-and-events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials","description":"Please join us ... When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\/\/us06web.zoom.us\/j\/82435258546, Meeting ID: 824 3525","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials","og_description":"Please join us ... When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\/\/us06web.zoom.us\/j\/82435258546, Meeting ID: 824 3525","og_url":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-14T13:27:39+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/","url":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/","name":"ICES | Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2022-11-28T05:00:00+00:00","dateModified":"2023-06-14T13:27:39+00:00","description":"Please join us ... When: Thursday, December 1, 2022, 12&#x2013;1 p.m. Where: Join Zoom Meeting https:\/\/us06web.zoom.us\/j\/82435258546, Meeting ID: 824 3525","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/parkinson-disease-progression-measures-in-health-services-data-laying-the-groundwork-for-studying-exposure-to-pgk1as-and-parkinson-disease-in-randomized-controlled-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Announcements & Events","item":"https:\/\/www.ices.on.ca\/fr\/announcements-and-events\/"},{"@type":"ListItem","position":3,"name":"Parkinson disease progression measures in health services data: laying the groundwork for studying exposure to PGK1as and Parkinson disease in randomized controlled trials"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/announce_or_event\/8629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/announce_or_event"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/announce_or_event"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6733"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=8629"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=8629"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=8629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}